These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1928268)

  • 1. Microbiologic aspects of fluoroquinolones.
    Neu HC
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quinolones.
    Neu HC
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
    Foster MT
    Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic focus. The fluoroquinolones.
    James DG
    Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with infectious gastroenteritis in New Zealand rarely need antimicrobial treatment.
    Voss LM; Ellis-Pegler RB
    N Z Med J; 2000 Jun; 113(1111):224-8. PubMed ID: 10909938
    [No Abstract]   [Full Text] [Related]  

  • 6. The place of quinolones in bacterial infections.
    Neu HC
    Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of urinary tract infections in the elderly: role of fluoroquinolones.
    Sant GR; Wainstein M
    Urology; 1990 Jan; 35(1 Suppl):19-21. PubMed ID: 2404371
    [No Abstract]   [Full Text] [Related]  

  • 8. The quinolones: decades of development and use.
    Emmerson AM; Jones AM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones: mechanism of action, classification, and development of resistance.
    Blondeau JM
    Surv Ophthalmol; 2004 Mar; 49 Suppl 2():S73-8. PubMed ID: 15028482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The future of quinolones].
    Gomis M; Ledesma F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):463-5. PubMed ID: 9011201
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents.
    Pau AK; Slone RB
    Lippincotts Prim Care Pract; 1999; 3(1):39-54. PubMed ID: 10214201
    [No Abstract]   [Full Text] [Related]  

  • 16. Enrofloxacin: a new antimicrobial agent.
    Schroder J
    J S Afr Vet Assoc; 1989 Jun; 60(2):122-4. PubMed ID: 2691696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of new quinolones against clinical isolates of Corynebacterium species].
    Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
    Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluoroquinolones: 2nd generation quinolones].
    Taurand S
    Soins; 1991 Feb; (545):I-II. PubMed ID: 2024184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.